Angitia Biopharmaceuticals (Series C)
Funding Details
Date Award
May 30, 2025
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount
$120,000,000
Company Info
Founding Year
2016
Market
Musculoskeletal diseases
Location
Woodland Hills, California, USA
Coinvestors
Bain Capital Life Sciences, Janus Henderson, OrbiMed, 3H Health Investment, Yonghua Capital, Legend Capital, Elikon Venture
Company Description

Angitia Biopharmaceuticals is developing treatments for serious musculoskeletal diseases like osteoporosis.

Links
Back to HomeBack to Biopharmaceuticals DealsView Funding Announcement